FULC
Price
$8.01
Change
+$0.10 (+1.26%)
Updated
Jul 10 closing price
Capitalization
426.98M
26 days until earnings call
TSHA
Price
$2.55
Change
+$0.01 (+0.39%)
Updated
Jul 10 closing price
Capitalization
664.29M
38 days until earnings call
Interact to see
Advertisement

FULC vs TSHA

Header iconFULC vs TSHA Comparison
Open Charts FULC vs TSHABanner chart's image
Fulcrum Therapeutics
Price$8.01
Change+$0.10 (+1.26%)
Volume$609.29K
Capitalization426.98M
Taysha Gene Therapies
Price$2.55
Change+$0.01 (+0.39%)
Volume$2.34M
Capitalization664.29M
FULC vs TSHA Comparison Chart in %
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. TSHA commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Buy and TSHA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (FULC: $8.01 vs. TSHA: $2.55)
Brand notoriety: FULC and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 102% vs. TSHA: 56%
Market capitalization -- FULC: $426.98M vs. TSHA: $664.29M
FULC [@Biotechnology] is valued at $426.98M. TSHA’s [@Biotechnology] market capitalization is $664.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, FULC is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 4 TA indicator(s) are bullish while TSHA’s TA Score has 4 bullish TA indicator(s).

  • FULC’s TA Score: 4 bullish, 4 bearish.
  • TSHA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both FULC and TSHA are a good buy in the short-term.

Price Growth

FULC (@Biotechnology) experienced а +15.75% price change this week, while TSHA (@Biotechnology) price change was +4.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

FULC is expected to report earnings on Nov 12, 2025.

TSHA is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($664M) has a higher market cap than FULC($427M). FULC YTD gains are higher at: 70.426 vs. TSHA (47.399). FULC has higher annual earnings (EBITDA): -8.94M vs. TSHA (-85.47M). FULC has more cash in the bank: 227M vs. TSHA (117M). FULC has less debt than TSHA: FULC (8.11M) vs TSHA (61.4M). FULC has higher revenues than TSHA: FULC (80M) vs TSHA (7.22M).
FULCTSHAFULC / TSHA
Capitalization427M664M64%
EBITDA-8.94M-85.47M10%
Gain YTD70.42647.399149%
P/E RatioN/A2.70-
Revenue80M7.22M1,107%
Total Cash227M117M194%
Total Debt8.11M61.4M13%
FUNDAMENTALS RATINGS
FULC: Fundamental Ratings
FULC
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FULCTSHA
RSI
ODDS (%)
Bearish Trend 1 day ago
71%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TBWAX20.580.01
+0.05%
Thornburg Better World International A
RRGIX7.11N/A
N/A
DWS RREEF Global Real Estate Secc Inst
CPOAX44.51N/A
N/A
Morgan Stanley Insight A
FSWCX12.86N/A
N/A
Fidelity SAI US Value Index
LHCCX17.69N/A
N/A
Lord Abbett Health Care C

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with SLS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then SLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+1.26%
SLS - FULC
48%
Loosely correlated
-0.26%
ANNX - FULC
40%
Loosely correlated
+1.08%
VRDN - FULC
39%
Loosely correlated
+0.53%
MRNA - FULC
36%
Loosely correlated
+4.54%
MLTX - FULC
34%
Loosely correlated
+1.24%
More